scispace - formally typeset
H

Hari Krishna Ananthula

Researcher at University of Cincinnati

Publications -  4
Citations -  182

Hari Krishna Ananthula is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Nilotinib & Cell morphology. The author has an hindex of 4, co-authored 4 publications receiving 154 citations.

Papers
More filters
Journal ArticleDOI

Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids

TL;DR: Two compounds found were highly effective in vitro and in vivo against several pathogenic fungi and were well tolerated by animals and additive to current antifungals, suggesting that these drugs might pave the way for the development of a new class of antIFungals.
Journal ArticleDOI

Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids.

TL;DR: Three out of 19 derivatives of BHBM were highly active against Cryptococcus neoformans in vitro and had low toxicity in mammalian cells, suggesting that acylhydrazones are promising molecules for the research and development of new antifungal agents.
Journal ArticleDOI

Erratum for Mor et al., "Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids".

TL;DR: Visesato Mor, a Antonella Rella, a Amir M. Farnoud, a Ashutosh Singh, a Mansa Munshi, a Arielle Bryan, a Shamoon Naseem, a James B. Konopka, a Iwao Ojima,b Erika Bullesbach,c Alan Ashbaugh,d Michael J. Linke, d,e Melanie Cushion,d,e Margaret Collins,e Hari Krishna Ananthula,
Journal ArticleDOI

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

TL;DR: Prairie dogs and monkeys may be suitable rodent and non-rodent species to perform further efficacy testing of these TKIs against orthopoxvirus infections, and allometry-based correlations, derived from existing literature data, may serve as a useful guide for pre-clinical PK studies in untested animal models.